Overview

Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects

Status:
Completed
Trial end date:
2022-07-22
Target enrollment:
Participant gender:
Summary
It is a single-center, open-label, Phase I clinical study evaluating the safety and pharmacokinetics of a single oral TPN171H in elderly subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Vigonvita Life Sciences